Drugs / SSR180711C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00602680 | Jan → Jul 2008 | Alzheimer disease | Sanofi | Terminated | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SSR180711C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00602680 ↗ |
| Known as | J2.849.107G | ChEMBL registry synonym — accepted as the source's own label CHEMBL559478 ↗ |
| Known as | SSR-180,711 | ChEMBL registry synonym — accepted as the source's own label CHEMBL559478 ↗ |
| Action | Activate | “Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist” CHEMBL559478 ↗ |
| Modality | Small molecule | — CHEMBL559478 ↗ |
| Target | CHRNA7 | “Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist” CHEMBL559478 ↗ |